Capsule Announces Reseller Agreement with InterSystems

InterSystemsCapsule Technologie, the leading global provider of medical device integration solutions, has signed a reseller agreement with InterSystems, a global leader in software for connected healthcare. Under the terms of the agreement, InterSystems will be authorized to resell Capsule's SmartLinx Medical Device Information System® (MDIS). The two companies' partnership stems from a shared vision of connected care and strong global market presence.

Capsule's SmartLinx MDIS is healthcare's first integrated system to enable hospitals and healthcare delivery organizations to increase efficiency and help improve patient care delivery through the capture of medical device data and context directly at the point of care. The system consolidates clinical workflow and puts data to work by integrating it with both electronic medical records and intelligent systems to drive informed clinical and operational decisions. Connectivity and data capture are achieved through integrated hardware and/or software solutions that meet the requirements of virtually any healthcare environment.

InterSystems TrakCare® is a unified healthcare information system that provides a comprehensive set of administrative and advanced clinical capabilities to rapidly enable a shared electronic medical record (EMR) across care settings. The partnership with Capsule will enable TrakCare customers to capture real-time observation data in ICU and operating theatres and store the data in the patient's EMR.

Both companies share a global presence while providing pre-configured solutions to meet the needs of local markets. "Establishing this partnership with Capsule is an exciting opportunity for both companies," said Christine Chapman, Vice President, TrakCare, at InterSystems. "The bundling of Capsule’s MDIS solution with TrakCare® will enable customers to seamlessly connect devices and make that data immediately available in the TrakCare EMR, triggering decision support, workflows and alerts for improved quality of care."

"Like InterSystems, Capsule works closely with our partners to localize our market strategy," said Didier Argenton, Capsule's Vice President of International Sales. "This agreement will facilitate entry into new markets and will contribute significantly in developing our presence worldwide."

Related news articles:

About Capsule
Capsule is the leading global provider of medical device integration solutions for hospitals and healthcare organizations. Capsule's SmartLinxMedical Device Information System® (MDIS) increases efficiency and helps improve patient care through the systematic real-time capture of patient vitals at the point-of-care and the delivery of those data to hospital electronic medical records, other information systems and third party mobile solutions. Capsule's solutions are flexible and scalable, offering a variety of deployment options to meet the needs of any healthcare delivery organization. Founded in 1997, the Company has established strong partnerships with leading medical device manufacturers and installed enterprise-wide solutions in over 1,800 hospitals in 38 countries.

About InterSystems
InterSystems develops advanced software technologies that enable breakthroughs. With a passion for excellence and a focus on client success, InterSystems provides data management, strategic interoperability, and analytics platforms used in healthcare, financial services, government, and other industries. In selected countries, InterSystems also offers unified healthcare applications, based on its core technologies, that deliver on the promise of connected healthcare. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its products are used daily by millions of people in more than 100 countries.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...